(Q48534825)

English

Positron emission tomography imaging of risperidone augmentation in serotonin reuptake inhibitor-refractory patients.

scientific article published on 16 May 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16707915

Positron emission tomography imaging of risperidone augmentation in serotonin reuptake inhibitor-refractory patients. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16707915

0 references

positron emission tomography

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Randall E. Newmark

6

object named as

Randall Newmark

0 references

2

object named as

Eric Hollander

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16707915

author name string

Monte S Buchsbaum

1

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16707915

Stefano Pallanti

3

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16707915

Nicolò Baldini Rossi

4

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16707915

Jimcy Platholi

5

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16707915

Rachel Bloom

7

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16707915

Erica Sood

8

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16707915

publication date

16 May 2006

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16707915

Neuropsychobiology

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16707915

53

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16707915

3

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16707915

157-168

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16707915

Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression

1 reference

https://api.crossref.org/works/10.1159%2F000093342

21 January 2018

Predictors of fluvoxamine response in contamination-related obsessive compulsive disorder: a PET symptom provocation study

1 reference

https://api.crossref.org/works/10.1159%2F000093342

21 January 2018

Adults with early-onset obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.1159%2F000093342

21 January 2018

Identifiers

10.1159/000093342

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16707915

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16707915

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48534825&oldid=1566640270"